Department Of Medicine 18
851. Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study
852. Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study
853. Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study
854. Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study
855. Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study
856. Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study
857. The case for simplifying and using absolute targets for viral hepatitis elimination goals
858. The case for simplifying and using absolute targets for viral hepatitis elimination goals
859. Immunology of acute and chronic wound healing
860. Novel Therapies for the Treatment of Cardiac Fibrosis Following Myocardial Infarction
861. Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019
862. Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019
863. Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019
864. Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019
865. Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019
866. Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019
867. Comparative effectiveness of adding delamanid to a multidrug-resistant tuberculosis regimen comprised of three drugs likely to be effective
868. Anti-Inflammatory, Antioxidant, and Anti-Atherosclerotic Effects of Natural Supplements on Patients with FMF-Related AA Amyloidosis: A Non-Randomized 24-Week Open-Label Interventional Study
869. The Relationship of the Pathogenic Variant rs721048 in the Intron of the EHBP1 Gene with the Development of Prostate Cancer and Colorectal Cancer in the Kazakh Population
870. COVID-19 vaccination in patients with heart failure: a position paper of the Heart Failure Association of the European Society of Cardiology
871. Beyond VEGF and TGF-β: A Comprehensive Review of Growth Factor Pathways in the Pathophysiology of Uterine Leiomyomas
872. Case Report: Unique management strategy for rare case of esophageal foreign body
873. Autoimmune rheumatic diseases and COVID-19 vaccination: a retrospective cross-sectional study from Astana
874. Comparison of CytoSorb and Jafron HA330 Hemoadsorption Devices in Pediatric Oncological Patients with Sepsis: Retrospective Observational Study
875. Predictors of All-cause Mortality among Hospitalized HIV Patients in Kazakhstan: a Retrospective Study
876. Biomarker urinary neutrophil gelatinase-associated lipocalin as a predictor of acute kidney injury in neonates
877. Biomarker urinary neutrophil gelatinase-associated lipocalin as a predictor of acute kidney injury in neonates
878. Mobilizing for Health: A Case Study of Kazakhstan’s Vaping Ban Advocacy Campaign
879. Insights into ancestral diversity in Parkinson’s disease risk: a comparative assessment of polygenic risk scores
880. Assessment of Surrogate Markers for Cardiovascular Disease in Familial Mediterranean Fever-Related Amyloidosis Patients Homozygous for M694V Mutation in MEFV Gene
881. Epidemiology of spontaneous pregnancy loss in Kazakhstan: A national population-based cohort analysis during 2014–2019 using the national electronic healthcare system
882. Epidemiology of tuberculosis in Kazakhstan: data from the Unified National Electronic Healthcare System 2014-2019
883. The Prevalence, Indications, Outcomes of the Most Common Major Gynecological Surgeries in Kazakhstan and Recommendations for Potential Improvements into Public Health and Clinical Practice: Analysis of the National Electronic Healthcare System (2014–2019)
884. In vitro cytotoxicity and antiviral activity of aminocaproic acid against SARS-CoV-2
885. In vitro cytotoxicity and antiviral activity of aminocaproic acid against SARS-CoV-2
886. In vitro cytotoxicity and antiviral activity of aminocaproic acid against SARS-CoV-2
887. The Worldwide Prevalence of Internet Addiction among Medical Students: A Systematic Review and Meta-Analysis
888. Chronic Pancreatitis-Induced Thrombosis of Celiac and Superior Mesenteric Artery
889. Probiotics and Fecal Transplant: An Intervention in Delaying Chronic Kidney Disease Progression?
890. Detection of the Frail Elderly at Risk of Postoperative Sepsis
891. History of Endometriosis Is Independently Associated with an Increased Risk of Ovarian Cancer
892. Population health and health services: Old challenges and new realities in the COVID-19 era
893. Towards an Accurate Estimation of COVID-19 Cases in Kazakhstan: Back-Casting and Capture–Recapture Approaches
894. Women’s Health and Gynecology: Old Challenges and New Insights
895. A Novel Classification of Endometriosis Based on Clusters of Comorbidities
896. Direct and Indirect Costs Related to Physical Activity Levels in Patients with Diabetes Mellitus in Spain: A Cross-Sectional Study
897. Systematic review and meta-analysis of incidence and prevalence of endometriosis
898. Nurse Managers’ Toxic Leadership Behaviors and Their Influence on Nurses’ Quality of Life: A Cross-Sectional Study
899. Mesenchymal stem cell-based therapy for rheumatoid arthritis
900. Recent advances to enhance the immunomodulatory potential of mesenchymal stem cells
1 16 17 18 19 20 24